SE9604751D0 - New therapy - Google Patents

New therapy

Info

Publication number
SE9604751D0
SE9604751D0 SE9604751A SE9604751A SE9604751D0 SE 9604751 D0 SE9604751 D0 SE 9604751D0 SE 9604751 A SE9604751 A SE 9604751A SE 9604751 A SE9604751 A SE 9604751A SE 9604751 D0 SE9604751 D0 SE 9604751D0
Authority
SE
Sweden
Prior art keywords
new therapy
medicament
oral
manufacture
treatment
Prior art date
Application number
SE9604751A
Other languages
English (en)
Swedish (sv)
Inventor
Roger Haellgren
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9604751A priority Critical patent/SE9604751D0/xx
Publication of SE9604751D0 publication Critical patent/SE9604751D0/xx
Priority to EEP199900258A priority patent/EE9900258A/xx
Priority to KR1019997005573A priority patent/KR20000069594A/ko
Priority to CZ992193A priority patent/CZ219399A3/cs
Priority to PCT/SE1997/002124 priority patent/WO1998027987A1/en
Priority to JP52868498A priority patent/JP2001507024A/ja
Priority to HU0000397A priority patent/HUP0000397A3/hu
Priority to US09/011,623 priority patent/US6432937B1/en
Priority to AU55025/98A priority patent/AU5502598A/en
Priority to PL97334012A priority patent/PL334012A1/xx
Priority to SK826-99A priority patent/SK82699A3/sk
Priority to IL13048597A priority patent/IL130485A0/xx
Priority to EP97951366A priority patent/EP0957922A1/en
Priority to CA002274769A priority patent/CA2274769A1/en
Priority to NZ336025A priority patent/NZ336025A/en
Priority to TR1999/01413T priority patent/TR199901413T2/xx
Priority to BR9713975-0A priority patent/BR9713975A/pt
Priority to IDW990480A priority patent/ID21763A/id
Priority to IS5056A priority patent/IS5056A/is
Priority to NO993066A priority patent/NO993066L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE9604751A 1996-12-20 1996-12-20 New therapy SE9604751D0 (sv)

Priority Applications (20)

Application Number Priority Date Filing Date Title
SE9604751A SE9604751D0 (sv) 1996-12-20 1996-12-20 New therapy
IDW990480A ID21763A (id) 1996-12-20 1997-12-16 Perawatan untuk peradangan persendian
AU55025/98A AU5502598A (en) 1996-12-20 1997-12-16 New treatment for joint inflammation
SK826-99A SK82699A3 (en) 1996-12-20 1997-12-16 Use of glucocorticoids having a minimal systemic effect in the manufacture of a medicament
CZ992193A CZ219399A3 (cs) 1996-12-20 1997-12-16 Použití glukokortikoidů s minimálním systémovým účinkem pro přípravu léku
PCT/SE1997/002124 WO1998027987A1 (en) 1996-12-20 1997-12-16 New treatment for joint inflammation
JP52868498A JP2001507024A (ja) 1996-12-20 1997-12-16 関節炎の新規処置
HU0000397A HUP0000397A3 (en) 1996-12-20 1997-12-16 The use of glucocorticoid substances pasessing a minimal systemic effect for producing pharmaceutical composition for the treatment of joint inflammation
US09/011,623 US6432937B1 (en) 1996-12-20 1997-12-16 Treatment for joint inflammation
EEP199900258A EE9900258A (et) 1996-12-20 1997-12-16 Liigesepõletiku uus ravi
PL97334012A PL334012A1 (en) 1996-12-20 1997-12-16 Novel method of treating the arthritis
KR1019997005573A KR20000069594A (ko) 1996-12-20 1997-12-16 관절염의 신규 치료 방법
IL13048597A IL130485A0 (en) 1996-12-20 1997-12-16 New treatment for joint inflammation
EP97951366A EP0957922A1 (en) 1996-12-20 1997-12-16 New treatment for joint inflammation
CA002274769A CA2274769A1 (en) 1996-12-20 1997-12-16 New treatment for joint inflammation
NZ336025A NZ336025A (en) 1996-12-20 1997-12-16 Use of a glucocorticoid containing composition to treat joint inflammation
TR1999/01413T TR199901413T2 (xx) 1996-12-20 1997-12-16 Eklem iltihab� i�in yeni tedavi.
BR9713975-0A BR9713975A (pt) 1996-12-20 1997-12-16 Novo tratamento para inflação de articulações
IS5056A IS5056A (is) 1996-12-20 1999-05-27 Ný meðhöndlun á liðbólgu
NO993066A NO993066L (no) 1996-12-20 1999-06-21 Ny behandling for leddinflammasjon

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9604751A SE9604751D0 (sv) 1996-12-20 1996-12-20 New therapy

Publications (1)

Publication Number Publication Date
SE9604751D0 true SE9604751D0 (sv) 1996-12-20

Family

ID=20405107

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9604751A SE9604751D0 (sv) 1996-12-20 1996-12-20 New therapy

Country Status (20)

Country Link
US (1) US6432937B1 (cs)
EP (1) EP0957922A1 (cs)
JP (1) JP2001507024A (cs)
KR (1) KR20000069594A (cs)
AU (1) AU5502598A (cs)
BR (1) BR9713975A (cs)
CA (1) CA2274769A1 (cs)
CZ (1) CZ219399A3 (cs)
EE (1) EE9900258A (cs)
HU (1) HUP0000397A3 (cs)
ID (1) ID21763A (cs)
IL (1) IL130485A0 (cs)
IS (1) IS5056A (cs)
NO (1) NO993066L (cs)
NZ (1) NZ336025A (cs)
PL (1) PL334012A1 (cs)
SE (1) SE9604751D0 (cs)
SK (1) SK82699A3 (cs)
TR (1) TR199901413T2 (cs)
WO (1) WO1998027987A1 (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2425858A3 (en) 2006-11-20 2012-03-28 President and Fellows of Harvard College Compositions for treating pain and pruritus
WO2010071865A1 (en) 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
US20100160351A1 (en) * 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
CA2767646C (en) 2009-07-10 2019-01-29 President And Fellows Of Harvard College Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
WO2011032175A1 (en) 2009-09-14 2011-03-17 Nuon Therapeutics, Inc. Combination formulations of tranilast and allopurinol and methods related thereto
JP6184328B2 (ja) 2011-02-18 2017-08-23 アサナ・バイオサイエンシズ，リミテッド・ライアビリティ・カンパニー アミノインダン化合物および疼痛治療におけるその使用
HUE032240T2 (en) 2011-10-24 2017-09-28 Asana Biosciences Llc cyclohexylamines
AU2014365823B2 (en) 2013-12-16 2019-05-02 Abs Development 1, Inc. P2X3 and/or P2X2/3 compounds and methods
AU2016301282B2 (en) 2015-08-03 2022-03-17 Children's Medical Center Corporation Charged ion channel blockers and methods for use
JP2016193937A (ja) * 2016-08-09 2016-11-17 株式会社エヌ・エル・エー 関節痛緩和組成物および機能性食品、並びに発酵ショウガ及びその製造方法
US10174039B2 (en) 2016-09-30 2019-01-08 Asana Biosciences, Llc P2X3 and/or P2X2/3 compounds and methods
CA3129089A1 (en) 2019-03-11 2020-09-17 Bridget Mccarthy Cole Ester substituted ion channel blockers and methods for use
US10828287B2 (en) 2019-03-11 2020-11-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
KR20210145166A (ko) 2019-03-11 2021-12-01 녹시온 테라퓨틱스 인코포레이티드 하전된 이온 채널 차단제 및 사용 방법
MA55318A (fr) 2019-03-11 2022-01-19 Nocion Therapeutics Inc Bloqueurs de canaux ioniques chargés et procédés d'utilisation
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
JP7513713B2 (ja) 2019-11-06 2024-07-09 ノシオン セラピューティクス，インコーポレイテッド 荷電したイオンチャンネル遮断薬および使用方法
IL292505A (en) 2019-11-06 2022-06-01 Nocion Therapeutics Inc Charged ion channel blockers and methods for use
US12162851B2 (en) 2020-03-11 2024-12-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
MX2022011194A (es) 2020-03-11 2022-11-08 Nocion Therapeutics Inc Bloqueadores de canales ionicos cargados y metodos de uso.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8903914D0 (sv) 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
CA2140660A1 (en) * 1993-06-13 1994-12-22 Uwe R. Juergens Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system

Also Published As

Publication number Publication date
CZ219399A3 (cs) 1999-09-15
NZ336025A (en) 2001-02-23
HUP0000397A3 (en) 2001-01-29
EE9900258A (et) 1999-12-15
EP0957922A1 (en) 1999-11-24
BR9713975A (pt) 2000-04-11
AU5502598A (en) 1998-07-17
JP2001507024A (ja) 2001-05-29
SK82699A3 (en) 2000-02-14
NO993066D0 (no) 1999-06-21
TR199901413T2 (xx) 1999-08-23
IL130485A0 (en) 2000-06-01
NO993066L (no) 1999-06-21
ID21763A (id) 1999-07-22
PL334012A1 (en) 2000-01-31
HUP0000397A2 (hu) 2000-10-28
CA2274769A1 (en) 1998-07-02
IS5056A (is) 1999-05-27
KR20000069594A (ko) 2000-11-25
US6432937B1 (en) 2002-08-13
WO1998027987A1 (en) 1998-07-02

Similar Documents

Publication Publication Date Title
SE9604751D0 (sv) New therapy
ID27504A (id) Formulasi oral baru
IL144294A0 (en) P53 inhibitors and therapeutic use of the same
YU37602A (sh) Derivat pirolidinacetamida sam ili u kombinaciji za tretman poremećaja cns
MY127812A (en) New use for budesonide and formoterol
CY1107512T1 (el) Νεες υποκατεστημενες με βενζιμιδαζολιο μορφες δοσολογιας και μεθοδος για τη χρηση τους
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
ATE212351T1 (de) Androsten-derivate
ES2166988T3 (es) Terapia de administracion uniforme de farmacos.
NO20004419L (no) Ny anvendelse
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
ATE291914T1 (de) Zolmitriptanhaltige arzneizusammensetzungen
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
DE69633396D1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
AU4179399A (en) Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders
NO20001717D0 (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
PT900563E (pt) Producao de formulacoes farmaceuticas para o tratamento de edema e doencas venosas
NO20005548D0 (no) Mykobakterieinhibitorer
DK1276477T3 (da) Medikamenter indeholdende pantothensyre til behandlingen af inflammatorisk ledsygdom
DK0927031T3 (da) Farmaceutisk sammensætning indeholdende nimesulid til oral admnistration
NO981320L (no) Oral anvendelse av (+)-O-demetyltramadol som smertemiddel
PT834316E (pt) Utilizacao da sulbutiamina para a obtencao de composicoes farmaceuticas uteis no tratamento de certas perturbacoes psicomotoras e psico-intelectuais
ATE232738T1 (de) Kolostrum enthaltende pharmazeutische zusammensetzungen und deren verwendung
UA32029A (uk) Лікарська плівка для терапії захворювань пародонту і слизової оболонки ротової порожнини